These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25596269)

  • 21. Iron metabolism and ineffective erythropoiesis in beta-thalassemia mouse models.
    Ramos P; Melchiori L; Gardenghi S; Van-Roijen N; Grady RW; Ginzburg Y; Rivella S
    Ann N Y Acad Sci; 2010 Aug; 1202():24-30. PubMed ID: 20712768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ineffective erythropoiesis and regulation of iron status in iron loading anaemias.
    Camaschella C; Nai A
    Br J Haematol; 2016 Feb; 172(4):512-23. PubMed ID: 26491866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.
    Gardenghi S; Grady RW; Rivella S
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1089-107. PubMed ID: 21075282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.
    Manolova V; Nyffenegger N; Flace A; Altermatt P; Varol A; Doucerain C; Sundstrom H; Dürrenberger F
    J Clin Invest; 2019 Dec; 130(1):491-506. PubMed ID: 31638596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia.
    Schmidt PJ; Racie T; Westerman M; Fitzgerald K; Butler JS; Fleming MD
    Am J Hematol; 2015 Apr; 90(4):310-3. PubMed ID: 25557851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
    Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
    Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia.
    Schmidt PJ; Liu K; Visner G; Fitzgerald K; Fishman S; Racie T; Hettinger JL; Butler JS; Fleming MD
    Am J Hematol; 2018 Jun; 93(6):745-750. PubMed ID: 29498084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What regulates hepcidin in poly-transfused β-Thalassemia Major: erythroid drive or store drive?
    Chauhan R; Sharma S; Chandra J
    Indian J Pathol Microbiol; 2014; 57(1):39-42. PubMed ID: 24739829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice.
    Li H; Choesang T; Bao W; Chen H; Feola M; Garcia-Santos D; Li J; Sun S; Follenzi A; Pham P; Liu J; Zhang J; Ponka P; An X; Mohandas N; Fleming RE; Rivella S; Li G; Ginzburg YZ
    Blood; 2017 Mar; 129(11):1514-1526. PubMed ID: 28151426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of hepcidin through GDF-15 in cancer-related anemia.
    Jiang F; Yu WJ; Wang XH; Tang YT; Guo L; Jiao XY
    Clin Chim Acta; 2014 Jan; 428():14-9. PubMed ID: 24384540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β- and α-Thalassemia intermedia in Basra, Southern Iraq.
    Abdulwahid DA; Hassan MK
    Hemoglobin; 2013; 37(6):553-63. PubMed ID: 23944608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of growth differentiation factor-15 are high and correlate with clinical severity in transfusion-independent patients with β thalassemia intermedia.
    Musallam KM; Taher AT; Duca L; Cesaretti C; Halawi R; Cappellini MD
    Blood Cells Mol Dis; 2011 Dec; 47(4):232-4. PubMed ID: 21865063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera.
    Casu C; Oikonomidou PR; Chen H; Nandi V; Ginzburg Y; Prasad P; Fleming RE; Shah YM; Valore EV; Nemeth E; Ganz T; MacDonald B; Rivella S
    Blood; 2016 Jul; 128(2):265-76. PubMed ID: 27154187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone.
    Diepeveen L; Roelofs R; Grebenchtchikov N; van Swelm R; Kautz L; Swinkels D
    PLoS One; 2021; 16(7):e0254851. PubMed ID: 34283879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.
    Millot S; Delaby C; Moulouel B; Lefebvre T; Pilard N; Ducrot N; Ged C; Lettéron P; de Franceschi L; Deybach JC; Beaumont C; Gouya L; De Verneuil H; Lyoumi S; Puy H; Karim Z
    Haematologica; 2017 Feb; 102(2):260-270. PubMed ID: 28143953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha and beta thalassemia.
    Muncie HL; Campbell J
    Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thalassemia: therapeutic hopes carried by hepcidin].
    Vaulont S; Labie D
    Med Sci (Paris); 2011 May; 27(5):473-5. PubMed ID: 21609665
    [No Abstract]   [Full Text] [Related]  

  • 38. Relation of hepcidin gene expression in blood mononuclear cells with iron overload severity among β-thalassemia major patients.
    Ayatollahi H; Mousavi Nezhad SF; Talebpour A; Badiei Z; Nezami H
    Mol Biol Rep; 2020 Dec; 47(12):9353-9359. PubMed ID: 33231816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Erythroferrone, Hepcidin, and Iron Overload Status in Iraqi Transfusion-Dependent β-Thalassemia Major Patients.
    Smesam HNK; Albuthabhak HAQ; Arjmand S; Al-Hakeim HK; R Siadat SO
    Hemoglobin; 2020 Jul; 44(4):272-277. PubMed ID: 32718192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between growth differentiation factor-15, erythroferrone, and iron status in thalassemic patients.
    Youssry I; Samy RM; AbdelMohsen M; Salama NM
    Pediatr Res; 2024 Mar; 95(4):1095-1100. PubMed ID: 37464096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.